Drug-resistant Tuberculosis Clinical Trial
Official title:
A Randomized, Open, Multicenter, Phase IIa Clinical Study on the Early Bactericidal Activity, Safety, Tolerance and Pharmacokinetics of JDB0131 Benzenesulfonate Tablets in Drug Sensitive Pulmonary Tuberculosis Patients
A randomized, open, drug controlled design of experiments was used to evaluate the early bactericidal activity, safety, tolerance and pharmacokinetic characteristics of JDB0131 benzenesulfonate tablet taken orally by drug sensitive pulmonary tuberculosis patients. Five groups are proposed to be set up in this test (JDB0131 benzenesulfonate 100mg BID, JDB0131 benzenesulfonate 200mg QD, JDB0131 benzenesulfonate 200mg BID, anti tuberculosis drug fixed dose composite dosage QD is determined according to the weight of the study participants, and delamanid 100mg BID)
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05017324 -
Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial
|
N/A | |
Active, not recruiting |
NCT04179500 -
A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis Volunteers
|
Phase 2 | |
Not yet recruiting |
NCT05553236 -
Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
|
N/A | |
Completed |
NCT02234908 -
Rewards for Tuberculosis Contact Screening
|
N/A | |
Completed |
NCT02236078 -
Brief Bactericidal Activity of Anti-Tuberculosis Drugs
|
Phase 1 | |
Completed |
NCT04147676 -
Evaluation of Centralised TB Assay Solutions
|
||
Completed |
NCT04493671 -
Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
|
Phase 1 | |
Completed |
NCT03338621 -
Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
|
Phase 2/Phase 3 | |
Completed |
NCT05526911 -
A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults
|
Phase 1 | |
Completed |
NCT03266003 -
An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment
|
N/A | |
Completed |
NCT04119375 -
Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes
|
N/A |